Show simple item record

dc.creatorPrieto, VA 
dc.creatorReyes, JM 
dc.creatorLopez-Cabra, C 
dc.creatorDiaz, JA 
dc.creatorUrrego-Novoa 
dc.date.accessioned2020-08-06T16:20:25Z
dc.date.available2020-08-06T16:20:25Z
dc.date.created2016-05-01
dc.identifier.issnISSN: 1098-3015
dc.identifier.issnEISSN: 1524-4733
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/25997
dc.description.abstractTo estimate the cost-effectiveness of sunitinib as first-line treatment for metastatic renal-cell carcinoma (mRCC) from the Colombian health system perspective.
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.relation.ispartofValue in Health, ISSN: 1098-3015 ; EISSN: 1524-4733, Vol.19, No.3 (May, 2016); pp.a149
dc.relation.urihttps://www.valueinhealthjournal.com/article/S1098-3015(16)01654-5/fulltext?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1098301516016545%3Fshowall%3Dtrue
dc.sourceValue in Health
dc.titlePCN87 Economic Evaluation of Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia
dc.typearticle
dc.publisherElsevier
dc.subject.keywordPublic Health and Health Services
dc.subject.keywordMedical and Health Sciences
dc.subject.keywordApplied Economics
dc.subject.keywordEconomics
dc.rights.accesRightsinfo:eu-repo/semantics/restrictedAccess
dc.type.spaArtículo
dc.rights.accesoRestringido (Acceso a grupos específicos)
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.identifier.doihttps://doi.org/10.1016/j.jval.2016.03.1586
dc.title.TranslatedTitlePCN87 Evaluación económica de Sunitinib como tratamiento de primera línea para el carcinoma de células renales metastásico en Colombia
dc.relation.citationIssueNo. 3
dc.relation.citationStartPagea149
dc.relation.citationTitleValue in Health
dc.relation.citationVolumeVol. 19


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record